Advertisement

Cyclin D1 overexpression induces replication stress and microhomology-mediated end-joining dependence in mantle cell lymphoma

Jithma Abeykoon,¹ Shuhei Asada,² Guangli Zhu,² Yuna Hirohashi,² Lisa Moreau,² Divya R. Iyer,² Sirisha Mukkavalli,² Kalindi Parmar,² Gabriella Zambrano,² Lige Jiang,¹ Dongni Yi,¹ Michelle Manske,³ Kimberly Gwin,¹ Rebecca L. King,⁴ James R. Cerhan,⁵ Xiaosheng Wu,³ Zhenkun Lou,⁷ Geoffrey I. Shapiro,⁸ Thomas Witzig,³ and Alan D'Andrea²

Published July 3, 2025 - More info

Oncogene expression can cause replication stress (RS), leading to DNA double-strand breaks (DSB) that require repair through pathways such as homologous recombination, non-homologous end-joining, and microhomology-mediated end-joining (MMEJ). Cyclin D1 (encoded by CCND1) is a well-known oncoprotein overexpressed in cancer; however, its role in RS is unknown. Using mantle cell lymphoma (MCL) as a naturally occurring model of cyclin D1 overexpression, we examined its impact on RS and DSB-repair mechanisms. Cyclin D1 overexpression elevated RS, increased DNA damage, especially during mitosis, and caused specific upregulation of MMEJ. Furthermore, cyclin D1 activates the polymerase theta (POLQ) transcription by binding its promoter loci, driving POLΘ-mediated MMEJ that is essential to withstand cyclin D1-induced RS. Moreover, concurrent ATM deficiency further intensifies RS, enhances POLQ expression and heightens reliance on MMEJ mediated DNA damage repair. Consequently, inhibition of POLΘ in cyclin D1-overexpressed settings further exacerbates RS, causing single-strand DNA gap accumulations and chromosomal instability, ultimately leading to apoptosis, an effect amplified in ATM-deficient cells. Targeting MMEJ via POLΘ inhibition is, therefore, an effective strategy in the context of cyclin D1 overexpression and ATM deficiency and may provide a unique therapeutic approach for treating MCL and other malignancies characterized by similar alterations.

Advertisement

Advertisement